TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vaccinia Sverige AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
10,316
|
7,694
|
5,835 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
1,789
|
1,003
|
16 |
| EBITDA |
1,757
|
1,019
|
50 |
| Total assets |
4,141
|
2,861
|
1,881 |
| Current assets |
4,121
|
2,825
|
1,823 |
| Current liabilities |
541
|
499
|
307 |
| Equity capital |
3,368
|
2,183
|
1,438 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.3%
|
76.3%
|
76.4% |
| Turnover per employee |
2,579
|
1,924
|
1,945 |
| Profit as a percentage of turnover |
17.3%
|
13.0%
|
0.3% |
| Return on assets (ROA) |
43.2%
|
35.1%
|
0.9% |
| Current ratio |
761.7%
|
566.1%
|
593.8% |
| Return on equity (ROE) |
53.1%
|
45.9%
|
1.1% |
| Change turnover |
2,076
|
2,035
|
-2,350 |
| Change turnover % |
25%
|
36%
|
-29% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.